CSL shares: 3 things you need to know ahead of the 2019 AGM

As CSL’s Annual General Meeting looms, the potential of a guidance upgrade gains increased visibility from one of Australia’s top brokers.

CSL share price: AGM in focus Source: Bloomberg

When will CSL hold their 2019 AGM?

The CSL Annual General Meeting (AGM) is set to be held next Wednesday, on October 16.

The meeting will be held at The Westin Sydney and will commence at 13:00 AEST.

Key topics of the AGM

As with most General Meetings, during CSL’s 2019 AGM a number of key Board members will seek to be re-elected.

Specifically, CSL’s Board has endorsed the re-election of both Ms Marie McDonald and Dr Megan Clark AC.

Beyond re-elections, Dr Tadataka who served on CSL’s Board and was a member of the Innovation and Development Committee, is set to retire following the AGM.

Besides this, the company noted that it is currently searching for, ‘a Non-executive Director with experience in the bio pharmaceutical industry and R&D/ Product Development.’

Secondly, shareholders will have a chance to vote on CSL’s Remuneration Report, as well as the company’s ‘Grant of Performance Share Units to Executive Directors’.

A number of high profile companies – including NAB, Westpac, Telstra and Harvey Norman – all received first strikes against their Renumeration Reports in 2018. For reference, if a company receives two strikes – that is, if two consecutive Renumeration Reports receive more than 25% of votes against the report, a company is required to vote on a board spill.

CSL, for reference, has seen no such ‘revolt’ from shareholders in recent times. Coincidentally, the CSL share price has also risen in excess of 200% in the last five years and more than 600% in the last decade.

CSL share price: why the AGM matters?

Morgan Stanley – as we covered previously – has a current price target of A$251 per share and an ‘overweight’ rating on the biotech giant CSL.

A central part of this bullish thesis revolves around CSL potentially upgrading its already impressive FY20 guidance of NPAT growth of between 7 to 10%.

Importantly, though the investment bank believes it is probably too early to see a guidance upgrade during the AGM, Morgan Stanley does point out that it is common for guidance to be re-affirmed, upgraded, or downgraded during Annual General Meetings.

On this front, Morgan Stanley sees an AGM guidance upgrade as only 30% likely (with the projected share price hitting A$260) if such an event were to occur. Most likely however, with a 60% probability thinks the investment bank, is for CSL to simply reaffirm its current FY20 guidance during the AGM.

Year-to-date, the CSL’s stock has run-up 29%.


This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

See opportunity on a stock?

Don’t miss your chance. Try a risk-free trade in your demo account, and find out whether your hunch could have paid off.

  • Log in to your demo
  • Try a risk-free trade
  • See whether your hunch pays off

See opportunity on a stock?

Don’t miss your chance. Upgrade to a live account to take advantage.

  • Trade a wide range of popular global stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform, when it matters

See opportunity on a stock?

Don’t miss your chance. Log in to take advantage while conditions prevail.

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
Bid
Offer
-
-
-
-
-
-
-
-
-
-
Bid
Offer
Bid
Offer
-
-
China 300
-
-

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Sunday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money. Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.